May 07, 2019 / 12:15PM GMT
Presentation
May 07, 2019 / 12:15PM GMT
=====================
Corporate Participants
=====================
* Camilla Sylvest
Novo Nordisk A/S - Executive VP and Head of Commercial Strategy & Corporate Affairs
* Karsten Munk Knudsen
Novo Nordisk A/S - Executive VP & CFO
* Mads Krogsgaard Thomsen
Novo Nordisk A/S - Executive VP & Chief Science Officer
* Maziar Mike Doustdar
Novo Nordisk A/S - Executive VP & Head of International Operations
=====================
Conference Call Participants
=====================
* Kerry Ann Holford
Exane BNP Paribas, Research Division - Analyst
* Keyur Parekh
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Peter Verdult
Citigroup Inc, Research Division - Director
* Peter James Welford
Jefferies LLC, Research Division - Senior Equity Analyst
* Sachin Jain
BofA Merrill Lynch, Research Division - MD
* Trung Chuong Huynh
Crédit Suisse AG, Research Division - Research
Novo Nordisk AS
(LTS:0QIU)
kr
768.35
-19.4 (-2.46%)
Market Cap: 3.46 Til
Enterprise Value: 3.46 Til
PE Ratio: 38.75
PB Ratio: 30.80
GF Score: 93/100 Q1 2019 Novo Nordisk A/S Earnings Presentation Transcript
May 07, 2019 / 12:15PM GMT
Release Date Price:
kr159.51
(-1.08%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers